Cleo received her PhD in Biological Sciences from University College London in 2001. She then spent four years as a MRC Career Development Fellow in the laboratory of Prof. Chris Higgins at the MRC Clinical Sciences Centre (now the London Institute of Medical Sciences), Imperial College London, where she developed a keen interest in cancer biology.
In 2006, she moved to the Blizard Institute to pursue her interest in senescence and cancer, spending four years in the laboratory of Prof. David Beach (FRS). During this time, she established our Phenotypic Screening facility, and has used this technology to discover novel regulators of the ageing and senescence biomarker, p16.
In 2010, Cleo was awarded a Lectureship, promoted to Senior Lecturer in 2016, to Reader in Senescence in 2020, and to Professor in 2022. She held the post of Director of Graduate Studies for the Blizard Institute from January 2018 – October 2021.
Cleo is the Director of The QMUL Phenotypic Screening Facility, managed by Dr Luke Gammon, and in 2018 became the Director of Graduate Studies for the Blizard Institute.
She also organises our cross-campus forums on ‘Senescence and Ageing’ and ‘Extracellular Vesicles’, and our award winning widening participation scheme, Blizard STARS.
Subject groups
-
Molecules of Life
Cell biology (incl molecular cell biology)
